Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Natural Tr1-like cells do not confer long-term tolerogenic memory.

Yadava K, Medina CO, Ishak H, Gurevich I, Kuipers H, Shamskhou EA, Koliesnik IO, Moon JJ, Weaver C, Nadeau KC, Bollyky PL.

Elife. 2019 Oct 11;8. pii: e44821. doi: 10.7554/eLife.44821.

2.

4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition.

Nagy N, Gurevich I, Kuipers HF, Ruppert SM, Marshall PL, Xie BJ, Sun W, Malkovskiy AV, Rajadas J, Grandoch M, Fischer JW, Frymoyer AR, Kaber G, Bollyky PL.

J Biol Chem. 2019 May 10;294(19):7864-7877. doi: 10.1074/jbc.RA118.006166. Epub 2019 Mar 26.

PMID:
30914479
3.

The bone marrow is patrolled by NK cells that are primed and expand in response to systemic viral activation.

Milo I, Blecher-Gonen R, Barnett-Itzhaki Z, Bar-Ziv R, Tal O, Gurevich I, Feferman T, Drexler I, Amit I, Bousso P, Shakhar G.

Eur J Immunol. 2018 Jul;48(7):1137-1152. doi: 10.1002/eji.201747378. Epub 2018 May 2.

4.

Active dissemination of cellular antigens by DCs facilitates CD8+ T-cell priming in lymph nodes.

Gurevich I, Feferman T, Milo I, Tal O, Golani O, Drexler I, Shakhar G.

Eur J Immunol. 2017 Oct;47(10):1802-1818. doi: 10.1002/eji.201747042.

5.

Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization.

Kuipers HF, Rieck M, Gurevich I, Nagy N, Butte MJ, Negrin RS, Wight TN, Steinman L, Bollyky PL.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1339-44. doi: 10.1073/pnas.1525086113. Epub 2016 Jan 19.

6.

Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation.

Stoler-Barak L, Petrovich E, Aychek T, Gurevich I, Tal O, Hatzav M, Ilan N, Feigelson SW, Shakhar G, Vlodavsky I, Alon R.

FASEB J. 2015 May;29(5):2010-21. doi: 10.1096/fj.14-265447. Epub 2015 Jan 29.

PMID:
25634957
7.

Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.

Challagundla P, Jorgensen JL, Kanagal-Shamanna R, Gurevich I, Pierson DM, Ferrajoli A, Reyes SR, Medeiros LJ, Miranda RN.

Arch Pathol Lab Med. 2014 Jul;138(7):903-9. doi: 10.5858/arpa.2013-0367-OA.

8.

Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.

Rudraiah S, Rohrer PR, Gurevich I, Goedken MJ, Rasmussen T, Hines RN, Manautou JE.

Toxicol Sci. 2014 Sep;141(1):263-77. doi: 10.1093/toxsci/kfu124. Epub 2014 Jun 27.

9.

The integrin coactivator Kindlin-3 is not required for lymphocyte diapedesis.

Cohen SJ, Gurevich I, Feigelson SW, Petrovich E, Moser M, Shakhar G, Fassler R, Alon R.

Blood. 2013 Oct 10;122(15):2609-17. doi: 10.1182/blood-2013-04-495036. Epub 2013 Aug 26.

PMID:
23980064
10.

Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.

Farache J, Koren I, Milo I, Gurevich I, Kim KW, Zigmond E, Furtado GC, Lira SA, Shakhar G.

Immunity. 2013 Mar 21;38(3):581-95. doi: 10.1016/j.immuni.2013.01.009. Epub 2013 Feb 7.

11.

Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Gurevich I, Zhang C, Francis N, Struzynsky CP, Livings SE, Aneskievich BJ.

Gene. 2013 Feb 15;515(1):42-8. doi: 10.1016/j.gene.2012.11.041. Epub 2012 Dec 8.

12.

Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.

Ophir E, Or-Geva N, Gurevich I, Tal O, Eidelstein Y, Shezen E, Margalit R, Lask A, Shakhar G, Hagin D, Bachar-Lustig E, Reich-Zeliger S, Beilhack A, Negrin R, Reisner Y.

Blood. 2013 Feb 14;121(7):1220-8. doi: 10.1182/blood-2012-07-441493. Epub 2012 Dec 5.

13.

Organotypic modeling of human keratinocyte response to peroxisome proliferators.

Zhang C, Gurevich I, Aneskievich BJ.

Cells Tissues Organs. 2012;196(5):431-41. doi: 10.1159/000336268. Epub 2012 Jun 5.

14.

Emerging roles for TNIP1 in regulating post-receptor signaling.

Ramirez VP, Gurevich I, Aneskievich BJ.

Cytokine Growth Factor Rev. 2012 Jun;23(3):109-18. doi: 10.1016/j.cytogfr.2012.04.002. Epub 2012 Apr 28. Review.

15.

TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Gurevich I, Zhang C, Francis N, Aneskievich BJ.

J Histochem Cytochem. 2011 Dec;59(12):1101-12. doi: 10.1369/0022155411427728.

16.

PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Gurevich I, Zhang C, Encarnacao PC, Struzynski CP, Livings SE, Aneskievich BJ.

Biochim Biophys Acta. 2012 Jan;1819(1):1-15. doi: 10.1016/j.bbagrm.2011.09.006. Epub 2011 Oct 7.

17.

TNIP1 is a corepressor of agonist-bound PPARs.

Flores AM, Gurevich I, Zhang C, Ramirez VP, Devens TR, Aneskievich BJ.

Arch Biochem Biophys. 2011 Dec 1;516(1):58-66. doi: 10.1016/j.abb.2011.08.014. Epub 2011 Sep 22.

18.

DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.

Tal O, Lim HY, Gurevich I, Milo I, Shipony Z, Ng LG, Angeli V, Shakhar G.

J Exp Med. 2011 Sep 26;208(10):2141-53. doi: 10.1084/jem.20102392. Epub 2011 Sep 19.

19.

Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.

King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M.

J Clin Oncol. 2011 Jun 1;29(16):2158-64. doi: 10.1200/JCO.2010.29.4041. Epub 2011 Apr 4.

PMID:
21464413
20.

Occult malignancy in patients undergoing contralateral prophylactic mastectomy.

King TA, Gurevich I, Sakr R, Patil S, Stempel M, Morrow M.

Ann Surg. 2011 Jul;254(1):2-7. doi: 10.1097/SLA.0b013e3182125b26.

PMID:
21372684
21.

Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings.

Gurevich I, Luthra R, Konoplev SN, Yin CC, Medeiros LJ, Lin P.

Am J Clin Pathol. 2011 Mar;135(3):398-403. doi: 10.1309/AJCPT0B6VEQPRCOA.

PMID:
21350094
22.

Scanning for transcription factor binding by a variant EMSA.

Gurevich I, Zhang C, Aneskievich BJ.

Methods Mol Biol. 2010;585:147-58. doi: 10.1007/978-1-60761-380-0_11.

PMID:
19908002
23.

Liganded RARalpha and RARgamma interact with but are repressed by TNIP1.

Gurevich I, Aneskievich BJ.

Biochem Biophys Res Commun. 2009 Nov 20;389(3):409-14. doi: 10.1016/j.bbrc.2009.08.159. Epub 2009 Sep 2.

24.

t(10; 12) (q24; p13) as the sole abnormality in a case with refractory acute myeloid leukemia: The first case report and literature review.

Lu G, Gurevich I, Vo BT, Chen SS.

Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Aug 18;41(4):480-3. Review.

25.

Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the spleen in a 26-year-old patient.

Sever M, Jorgensen JL, Gurevich I, Pinheiro M, Verstovsek S.

Leuk Res. 2009 Nov;33(11):e186-8. doi: 10.1016/j.leukres.2009.05.005. Epub 2009 May 30. No abstract available.

26.

Corepressors of agonist-bound nuclear receptors.

Gurevich I, Flores AM, Aneskievich BJ.

Toxicol Appl Pharmacol. 2007 Sep 15;223(3):288-98. Epub 2007 Jun 14. Review.

27.

Chronic lung disease and cystic fibrosis phenotype in prolidase deficiency: a newly recognized association.

Luder AS, Mandel H, Khayat M, Gurevich I, Frankel P, Rivlin J, Falik-Zaccai TC.

J Pediatr. 2007 Jun;150(6):656-8, 658.e1.

PMID:
17517257
28.

[Bacterial leaching of manganese ores].

Belyĭ AV, Pustoshilov PP, Gurevich IuL, Kadochnikova GG, Ladygina VP.

Prikl Biokhim Mikrobiol. 2006 May-Jun;42(3):327-31. Russian.

PMID:
16878550
29.

Nutritional upregulation of p85alpha expression is an early molecular manifestation of insulin resistance.

Cornier MA, Bessesen DH, Gurevich I, Leitner JW, Draznin B.

Diabetologia. 2006 Apr;49(4):748-54. Epub 2006 Feb 21.

PMID:
16491394
30.

Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.

Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, Leroith D, Kahn CR, Cantley LC, Friedman JE, Draznin B.

J Biol Chem. 2005 Nov 11;280(45):37489-94. Epub 2005 Sep 8.

31.

Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women.

Cornier MA, Donahoo WT, Pereira R, Gurevich I, Westergren R, Enerback S, Eckel PJ, Goalstone ML, Hill JO, Eckel RH, Draznin B.

Obes Res. 2005 Apr;13(4):703-9.

32.

Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection.

Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, Gurevich A.

J Infect. 2005 May;50(4):296-305.

PMID:
15845427
33.

[Correction of phagocyte functional activity in inflammatory focus in patients with deep phlegmons of the neck].

Tseĭmakh EA, Tulupov VA, Gurevich IuIu, Meliksetian TD, Golev LB, Shuster LV, Iazykov VA.

Stomatologiia (Mosk). 2004;83(4):37-41. Russian.

PMID:
15340303
34.

Dendrite development regulated by CREST, a calcium-regulated transcriptional activator.

Aizawa H, Hu SC, Bobb K, Balakrishnan K, Ince G, Gurevich I, Cowan M, Ghosh A.

Science. 2004 Jan 9;303(5655):197-202.

35.
36.

Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission.

Gurevich I, Englander MT, Adlersberg M, Siegal NB, Schmauss C.

J Neurosci. 2002 Dec 15;22(24):10529-32.

37.

Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly.

Tal S, Gurevich A, Guller V, Gurevich I, Berger D, Levi S.

Scand J Infect Dis. 2002;34(8):594-7.

PMID:
12238576
38.

Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.

Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C.

Neuron. 2002 Apr 25;34(3):349-56.

39.

[Effect of optic aberrations, caused by ablation pattern decentration after laser vision correction, on visual acuity].

Semchishen V, Mrokhen M, Gurevich I, Saĭler T.

Vestn Oftalmol. 2001 Nov-Dec;117(6):16-20. Russian.

PMID:
11845686
40.

[Electron microscopic study of the colonies of an alkylsulfonate-utilizing bacterial consortium].

Mogil'naia OA, Puzyr' AP, Gurevich IuL, Babkina EA.

Mikrobiologiia. 2001 Jul-Aug;70(4):543-51. Russian.

PMID:
11558282
41.

[Treatment in diffuse phlegmons of the neck].

Tseĭmakh EA, Tulupov VA, Gurevich IuIu, Zaĭtsev VA.

Vestn Khir Im I I Grek. 2001;160(2):35-8. Russian.

PMID:
11496490
42.

[Colony structure of a consortium of nitrogen-fixing bacteria].

Puzyr' AP, Mogil'naia OA, Gurevich IuL, Babkina EA.

Mikrobiologiia. 2001 Jan-Feb;70(1):98-105. Russian.

PMID:
11338844
43.
44.

[Indirect electrochemical oxidation of blood plasma in combined treatment of patients with acute mediastinitis].

Tseĭmakh EA, Gurevich IuIu, Tulopov VA, Zaĭtsev VA, Semenov VP, Serebriakov EN.

Khirurgiia (Mosk). 2000;(9):52-5. Russian.

PMID:
11026204
45.

[Protist plankton from the Khanka lake].

Ladygina VP, Gurevich IuL.

Izv Akad Nauk Ser Biol. 2000 May-Jun;(3):361-7. Russian.

PMID:
10868062
46.

[Flocculation of bacterial cells in culture with protozoa].

Gurevich IuL, Teremova MI, Latyntseva AV.

Izv Akad Nauk Ser Biol. 1998 May-Jun;(3):351-5. Russian.

PMID:
9644909
47.

Unreliability of chemical integrators compared to spore tests for sterilizer monitoring.

Gurevich I, Jacobsen E, Cunha BA.

Am J Infect Control. 1996 Oct;24(5):405-6. No abstract available.

PMID:
8902117
48.

Pseudoautoclave failure caused by differences in spore test steam sensitivities.

Gurevich I, Jacobsen E, Cunha BA.

Am J Infect Control. 1996 Oct;24(5):402-4. No abstract available.

PMID:
8902116
49.

Pseudoepidemic of nontuberculous mycobacteria in a community hospital.

Jacobsen E, Gurevich I, Schoch P, Cunha BA.

Infect Control Hosp Epidemiol. 1996 Jun;17(6):348. No abstract available.

PMID:
8805062
50.

Smear negative, culture positive AFB bronchial washings. Infection control implications.

Gurevich I, Jacobsen E, Ortega A, Cunha BA.

Chest. 1996 May;109(5):1410-1. No abstract available.

PMID:
8625704

Supplemental Content

Loading ...
Support Center